changes in rates of vasomotor symptom reporting over the menopausal transition, particularly among non-White women. Two studies have shown higher symptom rates among African American women, [3] [4] [5] [6] whereas another has not. 7 Several studies have reported reduced frequencies of symptoms among Asian women. 3, [8] [9] [10] [11] [12] [13] Because
Asian women tend to weigh less than African American women, these findings are contrary to the expectation that fewer heavier women will experience vasomotor symptoms owing to the greater estrone production in peripheral fat that stems from aromatization of androstenedione. [14] [15] [16] Thus, differences in other factors are likely to account for ethnic differences in vasomotor symptoms. In addition to differences in body size, hypotheses regarding racial/ethnic differences in reports of vasomotor symptoms include differences in hormone levels, 17, 18 socioeconomic status, 3, 7, [19] [20] [21] [22] [23] [24] active or passive exposure to tobacco smoke, 4, 7, 19, 21, [24] [25] [26] [27] diet, [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] physical activity, 3, 39 and psychosocial factors. 4, 5 Determining whether race/ ethnicity-specific differences in rates of vasomotor symptoms are independent of these factors will help clarify the physiology of such symptoms and provide valuable information for women and clinicians about high-risk groups and potential behavioral interventions.
Most previous studies of non-White women have not been longitudinal or community based, nor have their analyses adjusted for confounding factors. The longitudinal data and diverse ethnic groups included in the Study of Women's Health Across the Nation (SWAN) provided an opportunity to examine whether racial/ethnic differences in vasomotor symptoms persist as women undergo the perimenopausal transition, whether changes in symptom rates over the transition vary according to race/ethnicity, and whether racial/ ethnic differences can be explained by differences in the factors just described. Our hypotheses were as follows:
1. Within each menopausal transition category, more African American and Hispanic and fewer Chinese and Japanese women than White women will report vasomotor symptoms, but the relative amount of change in vasomotor symptoms as women progress from one perimenopausal transition stage to the next will not differ according to race/ethnicity. 2. Racial/ethnic differences in the occurrence of vasomotor symptoms will be independent of differences in socioeconomic status, menopausal status, body mass index (BMI), active or passive tobacco smoke exposure, dietary phytoestrogen intake, caffeine or alcohol consumption, physical activity level, premenstrual symptoms, symptom sensitivity, depression, anxiety, perceived stress, and social support. 3. Racial/ethnic differences in the occurrence of vasomotor symptoms will not vary according to educational attainment, BMI, or menopausal status.
 RESEARCH AND PRACTICE 
METHODS Study Population
In SWAN, 16 065 women at 7 sites underwent a screening interview during 1995 to 1997 to assess their eligibility for a longitudinal cohort. 40 Each site screened one minority population (African American women in Pittsburgh, Boston, the Detroit area, and Chicago; Japanese women in Los Angeles; Chinese women in the Oakland, Calif, area; and Hispanic women in New Jersey) and one White population taken from a communitybased sample of women aged 40 to 55 years residing near the site. Women who spoke English or Spanish (New Jersey), Cantonese (Oakland), or Japanese (Los Angeles) were eligible. Baseline eligibility criteria included the following: age 42 to 52 years, intact uterus and at least one ovary, not currently using exogenous hormones affecting ovarian function, menstrual period in the previous 3 months, and self-identification as a member of a site's designated racial/ethnic group. Each site recruited approximately 450 eligible participants (a total of 3302), and annual clinical examinations were conducted. We excluded women who had missing baseline data on vasomotor symptoms (n = 104) or missing covariate data (n = 414) from the present longitudinal analyses, which included data through the fifth annual visit (2001) (2002) . Thus, the sample size for our final multivariate longitudinal models (including baseline through the fifth annual visit) was 2784. Each woman could contribute up to 6 observations; the average number of observations was 4.3. The overall SWAN retention rate was 79.3% through the fifth visit.
Data Collection
The 3-hour baseline and 2-hour annual clinic visits included an in-person interview, self-administered questionnaires, and measurement of weight, height (with calibrated scales and a stadiometer), and waist and hip circumferences. Common protocols were used at all sites, and all study staff were trained and certified in administering the protocols. All data collection instruments were translated into Cantonese, Japanese, and Spanish and back-translated; discrepancies in translation were resolved by a pair of translators.
Outcomes
At each annual visit, participants reported the number of days in the preceding 2 weeks they had experienced each of 3 vasomotor symptoms (hot flashes, cold sweats, and night sweats). 17, 41, 42 Factor analyses showed similarly high single-factor loadings for these symptoms (cold sweats, 0.73; night sweats, 0.75; hot flashes, 0.68), indicating that they were substantially correlated. Thus, all 3 were considered vasomotor symptoms, and these symptoms were evaluated in 2 different ways. First, we compared characteristics of women reporting any versus no vasomotor symptoms in the previous 2 weeks. Second, we compared women reporting 6 or more days of any vasomotor symptoms (as an indicator of severity and a more clinically meaningful outcome) with women reporting no or fewer than 6 days of symptoms.
Independent Variables
Primary race/ethnicity was self-reported as Black or African American, non-Hispanic White, Chinese or Chinese American, Japanese or Japanese American, or Hispanic (Central American, Cuban or Cuban American, Dominican, Mexican or Mexican American, Puerto Rican, South American, Spanish or other Hispanic). Menopausal status was classified as premenopausal, indicating a menstrual period in the previous 3 months and no change in menstrual regularity in the preceding year; early perimenopausal, indicating menses in the previous 3 months and changes in regularity in the past year; late perimenopausal, indicating no menses in the previous 3 months but menses in the preceding 11 months; or postmenopausal, indicating 12 or more months of amenorrhea. Women who had undergone a hysterectomy or bilateral oophorectomy (or both) or who had begun using menopausal hormone therapy during follow-up were censored in the analyses at the time of surgery or hormone therapy initiation (n = 807 as the fifth visit).
Covariates
Demographic variables assessed for confounding (the presence of an association at P < .15 with race/ethnicity and vasomotor symptom reporting) included age, income, education, employment, difficulty paying for basic necessities (food, shelter, and heat), marital status, parity, and site. Psychosocial variables included symptom sensitivity at the first follow-up visit (1997-1998) (summed score of degree of awareness of loud noise, hot or cold, hunger, pain, and things happening in one's body; sensitivity ratings ranged from not at all true [1] to extremely true [5] ), 43 social support (summed scale assessing how often 4 types of needed emotional and instrumental support were available; responses ranged from none of the time [0] to all of the time [4] ), 44 perceived stress (summed scale assessing how often over the preceding 2 weeks 4 aspects of stress were experienced; responses ranged from never [1] to very often [5] ), 45 depressive symptoms (score of 16 or above on a 20-item scale assessing the extent to which each item had been experienced in the previous week), 46 anxiety (summed score of numbers of days in the past 2 weeks in which 4 symptoms [irritability or grouchiness, feeling tense or nervous, pounding or racing heart, fearful for no reason] were experienced; responses ranged from no days [0] to every day [4] ), and preferred language for reading and speaking (as a measure of acculturation). 47 BMI was measured as weight in kilograms divided by height in meters squared. Women were classified as having a history of premenstrual symptoms if, at baseline, they reported that they had experienced abdominal cramps, breast tenderness, bloating, or mood changes in the previous year during at least half of their menstrual periods or in the week before them. Validated questions were used to obtain information on current smoking status 48 and total person-hours per week of environmental tobacco smoke exposure. 49 
Data Analyses
We used χ 2 tests and analyses of variance to compute summary statistics for the study population and the frequency of vasomotor symptoms according to race/ ethnicity, menopausal transition stage, and covariates. To identify characteristics that were independently associated with vasomotor symptoms, we estimated multivariate longitudinal random (mixed) effects logistic regression models 57 using the Stata (Stata Corp, College Station, Tex) xtlogit procedure. This strategy permitted women to contribute different numbers of observations and to remain in the models even if they missed visits. By including random intercepts in the regression models, this approach also accounted for correlations between repeated observations for each woman resulting from the longitudinal design. These random intercepts were woman-specific terms indicating that each woman had a different starting value and that the correlation matrix varied from one woman to another. The parameter estimates thus involved a woman-specific interpretation; that is, as an example, odds ratios could be interpreted as the odds of vasomotor symptoms for an early or late perimenopausal woman relative to when she was premenopausal.
Multivariate models were constructed for 2 binary outcomes: any versus no vasomotor symptoms and any symptoms for 6 or more days versus no or fewer than 6 days of symptoms in the previous 2 weeks. Factors associated with vasomotor symptoms in the bivariate analyses (at P < .15) or identified from the literature as potential covariates were included in these models. Age, menopausal status, marital status, social support, employment status, smoking status, and BMI were time-dependent variables. Race/ ethnicity and menopausal status were forced into the final multivariate models, which included variables associated with both vasomotor symptoms and race/ethnicity at the P < .15 level. We used backward elimination (retaining variables significant at P < .05) to obtain a final parsimonious multivariate model. Interactions of race/ethnicity with menopausal status, BMI, and education were tested to evaluate whether observed racial/ethnic differences in vasomotor symptoms varied according to physiology (menopausal status or BMI) or to reporting tendencies that might be reflected by educational level.
RESULTS

Sample Characteristics
At baseline, all covariates other than age differed significantly according to race/ethnicity (Table 1 ). In comparison with the other racial/ethnic groups at baseline, higher percentages of Chinese and Japanese women were premenopausal, reported low levels of environmental tobacco smoke exposure, and reported fewer premenstrual, depressive, or anxiety symptoms. Relative to other racial/ ethnic groups, significantly greater proportions of Hispanic women had less than a high school education, reported an annual income below $20 000, read or spoke no English, reported having difficulty paying for basic necessities, and were unemployed. Hispanic women also had the lowest physical activity scores and the highest perceived stress scores. White women were least likely to be parous and had the highest daily intake of alcohol and the highest physical activity scores. African American women were the group most likely to be current smokers, and they were least likely to be married or have a partner; also, their BMIs and rates of environmental tobacco smoke exposure were highest.
Unadjusted Analyses
At baseline, 11.4% of women reported 6 or more days of vasomotor symptoms in the previous 2 weeks, whereas 28.8% reported 1 to 5 days of symptoms and 59.8% reported no vasomotor symptoms. As of the fifth visit, 21.2% reported 6 or more days of vasomotor symptoms in the preceding 2 weeks, 34.3% reported 1 to 5 days of symptoms, and 44.5% reported no vasomotor symptoms. Compared with women reporting fewer than 6 days of symptoms within the previous 2 weeks, women reporting 6 or more days of symptoms at baseline were significantly less educated, less likely to be employed, and more likely to smoke or to have been exposed to environmental tobacco smoke. In addition, they were more likely to report premenstrual symptoms, to be depressed or anxious, and to be older, heavier, and less physically active (Table 2 ). Finally, they had significantly lower annual household incomes and more difficulty in paying for basic necessities, reported less alcohol consumption, had higher symptom sensitivity and perceived stress scores, and reported lower genistein intakes.
We computed unadjusted, race-specific rates of vasomotor symptoms for the first visit at which a change in menopausal status was observed for each woman. A woman could thus contribute more than one observation to the data presented in the 2 panels of Figure 1 . Rates of reports of any vasomotor symptoms ( Figure 1a ) and any symptoms for 6 or more days (Figure 1b ) in the previous 2 weeks showed similar patterns according to race/ ethnicity and change in menopausal status, although rates for the former were generally higher. The highest rates were observed among African American women across all stages of the perimenopausal transition. Asian women had the lowest rates in most stages of the transition. In the case of all women, rates were highest in the early perimenopausal to late perimenopausal transition. Changes in rates in the late perimenopausal to postmenopausal transition, compared with the early to late perimenopausal transition, varied among the racial/ethnic groups.
Multivariate Models
Four final random effects models were estimated: a full model and a backward stepwise regression model for each of the 2 outcomes (any vs no vasomotor symptoms and any symptoms for 6 or more days vs no symptoms Continued or vasomotor symptoms for fewer than 6 days in the previous 2 weeks). Because the results of all 4 models were similar for significant variables and more frequent reports of symptoms may be more clinically meaningful, we describe, for the entire cohort and for each racial/ethnic group, only the full models focusing on 6 or more days of vasomotor symptoms.
In the case of all racial/ethnic groups other than Hispanics, the transition to late perimenopause was associated with the highest odds ratio for vasomotor symptoms (Table 3) . African American women had a significantly elevated symptom odds ratio compared with White women. For the cohort overall, age, increasing BMI, less than a college education, current smoking, history of premenstrual symptoms, higher symptom sensitivity at the first follow-up visit, and more baseline anxiety and depressive symptoms were significantly, independently, and positively associated with reports of 6 or more days of vasomotor symptoms. These factors were also associated with symptoms in most of the racial/ethnic subgroups assessed; however, they were not always statistically significant owing to the small numbers of women in some of these groups who reported experiencing symptoms for 6 or more days.
Symptom sensitivity was significantly related to vasomotor symptoms only among African American and Japanese women. Baseline anxiety was significantly, strongly related to symptoms in all ethnic groups with the exception of Hispanics. Baseline depressive symptoms were positively associated with symptoms in all of the racial/ethnic groups, but the association was significant only among White and Hispanic women. The other covariates assessed were not significantly related to vasomotor symptoms in the multivariate models.
None of the interactions of race/ethnicity with education, BMI, or menopausal status were statistically significant, and thus they were not included in the final adjusted models. Two additional multivariate analyses were conducted: one in which observations among hormone therapy users (8% of all observations) were not censored, because these data were likely to reflect more severely symptomatic women, and one that included only Continued women who reported no vasomotor symptoms at baseline, to reflect better the factors related to vasomotor symptom incidence. The same variables shown in Table 3 remained significant in these 2 models (data not shown), and, although ethnic group sample sizes were small, point estimates were similar in magnitude to those in Table 3 .
DISCUSSION
This study is among the first, to our knowledge, to examine vasomotor symptoms longitudinally in a multiethnic sample of women undergoing the perimenopausal transition. We found that, of the factors assessed, menopausal status was most strongly related to vasomotor symptoms. In all racial/ethnic groups, vasomotor symptom reports increased dramatically as women progressed from premenopause to early perimenopause and even more dramatically as they made the transition to late perimenopause. Absolute rates differed according to race/ethnicity, indicating innate physiological or cultural differences in reporting. Compared with White women, significantly more African American women and fewer (although not significantly fewer) women from the other 3 racial/ethnic groups reported vasomotor symptoms.
As women became postmenopausal, their vasomotor symptom reporting remained nearly as high as in late perimenopause, except in the case of Japanese and Hispanic women. However, the numbers of these women (along with Chinese women) who made the transition to postmenopause were small, and most had been postmenopausal for less than 3 years; thus, the effect estimates for this category might not have been stable. Additional follow-up of the SWAN cohort is necessary to determine whether symptom reporting declines or remains high with increased passing of time after women's final menstrual periods. In addition, those who made the transition earlier (i.e., stopped menstruating by the fifth visit) might not have been representative of all of those making the transition to postmenopause (e.g., the former were more likely to smoke and to have completed fewer years of education). 58 Many factors were related to vasomotor symptoms independent of race/ethnicity and  RESEARCH AND PRACTICE  Note. VMS = vasomotor symptoms. Prevalence was computed at the first visit at which a change in menopausal status was observed; women could thus contribute only one observation to each menopausal transition status category but could contribute more than one observation by progressing to different categories over the 5-year follow-up. Thus, observations in the 4 menopausal transition status categories were not mutually exclusive. Note. All models were full models that included variables associated with vasomotor symptoms at the P < .15 level; all odds ratios were adjusted for all of the variables listed and were adjusted for study site. Data shown are for baseline through the fifth visit. Frequent symptoms were defined as reports of 6 or more days of symptoms (vs reports of no or fewer than 6 days of symptoms) in the previous 2 weeks. a Abdominal cramps, breast tenderness, bloating, or mood changes. *P < .05; **P < .01; ***P < .001.
reports among White and Japanese women, and again we observed positive associations in all racial/groups. Symptom sensitivity was a significant factor among African American and Japanese women. Baseline depressive symptoms were a significant factor only among White and Hispanic women, although we observed positive associations between depressive symptoms and reports of vasomotor symptoms in all racial/ethnic groups.
Consistency With Previous Findings
Ethnic differences in vasomotor symptom reporting similar to those found here have been reported previously, 3, 5, 7, 8, 10, 59 although no studies, to our knowledge, have examined longitudinal changes in vasomotor symptoms and changes in menopausal status according to race/ethnicity. We have shown previously that differences in symptom reporting are not due to speaking a language other than English. 3 Increased vasomotor symptom reporting among African American women might be due to differences in perception and tolerance of temperatures. Several experimental studies have shown that African Americans have lower levels of tolerance to cold 60 and heat 61, 62 than Whites and that more African Americans than Whites rate heat as being unpleasant. 61 Thus, ethnic differences in perceptions and tolerance of thermal discomfort may extend to perceptions and reporting of vasomotor symptoms. In contrast to the expectation that higher BMIs will have a protective effect owing to higher estrone production, [14] [15] [16] the positive relation of BMI to vasomotor symptoms observed in our previous cross-sectional baseline examination 4 was found again in this study and has been reported by others. 6, 18, 19, 63 We observed a statistically significant positive association between BMI and vasomotor Finally, our results indicate no effects of physical activity or caffeine or alcohol intake on reports of vasomotor symptoms, suggesting that changes in these behaviors are not likely to significantly influence vasomotor symptom reporting. The lack of an association with physical activity was consistent with some 4, 39, 72 but not all 23, [73] [74] [75] [76] [77] previous studies; studies of the relationship between alcohol consumption and vasomotor symptoms have shown no 4, 7 or modest effects. 6 
Limitations and Strengths
In this longitudinal study, we assessed several factors in terms of their relationship to vasomotor symptoms, and thus any results that are significant at a borderline level must be interpreted cautiously. Also, measurement error was possible as a result of the data collection methods used in SWAN, and the possibility of such error was heightened in that some measures were selfreported and attempts were made to obtain data on comparable measures in 4 languages. Finally, the prevalence odds ratios presented here were overestimates of relative risks because the outcome (vasomotor symptoms) was not rare, with symptom reports ranging up to 80% in some subgroups.
A strength of the present study is that it was among the first to examine longitudinal changes in symptom reporting in a large, racially and ethnically diverse sample of midlife women experiencing the transition to perimenopause. This feature of the study, combined with the community-based sampling used in SWAN, allowed greater representativeness and thus enhanced the generalizability of the results. In addition, our careful control of a comprehensive set of demographic, reproductive, and medical variables in our multivariate models reduced the likelihood that the results were due to uncontrolled confounding.
Conclusions
We have produced new evidence that vasomotor symptoms are more strongly associated with changes in menopausal status than with other factors, particularly in the transition to late perimenopause. The strength of the association of symptom reporting with changes in menopausal status varied somewhat according to race/ethnicity, and racial/ ethnic differences in symptoms persisted after adjustment for other factors.
Older age, lower levels of educational attainment, and anxiety at baseline were independently associated with increased reports of vasomotor symptoms in all of the racial/ ethnic groups assessed with the exception of Hispanics. Increased BMI was associated with vasomotor symptom reports in all racial/ethnic groups, although significantly so only among Whites. Smoking, baseline depression, and premenstrual symptoms were positively associated with symptoms in the overall cohort. No significant associations were found with physical activity, dietary genistein, or alcohol or caffeine consumption. In summary, our findings suggest that vasomotor symptoms are frequently reported by midlife women, vary according to race/ethnicity over the menopausal transition, and are influenced by potentially modifiable factors such as smoking and body mass.
